MTHFR Polymorphism, Higher Homocysteine Up Cataract Risk

This article originally appeared here.
Share this content:
MTHFR Polymorphism, Higher Homocysteine Up Cataract Risk
MTHFR Polymorphism, Higher Homocysteine Up Cataract Risk

FRIDAY, March 18, 2016 (HealthDay News) -- Methylenetetrahydrofolate reductase (MTHFR) polymorphism and elevated homocysteine levels contribute to the risk of cortical cataract, separately and together, according to a study published online March 17 in JAMA Ophthalmology.

Ava Grace Tan, M.P.H., from the Westmead Institute for Medical Research in Australia, and colleagues examined the correlations of MTHFR polymorphisms and serum homocysteine levels with incident cortical cataract. Data were included for 3,654 residents of the Blue Mountains region aged 49 years and older, enrolled in 1992 to 1994. Participants were surveyed in 1997 to 1999 (2,334 participants) and 2002 to 2004 (1,952 participants); homocysteine levels were assessed in 1997 to 1999 and the five-year incidence of cataract was estimated. Two MTHFR polymorphisms were assessed.

The researchers observed independent correlations for C677T polymorphisms (CT/TT versus CC) and elevated homocysteine levels (>15 µmol/L) with increased risk of cortical cataract (odds ratios, 1.50 and 2.24, respectively). Homocysteine levels partially mediated the genetic effect on cortical cataract. The risk of cortical cataract was increased with combined CT/TT genotypes and elevated homocysteine levels (odds ratio, 3.74). For both exposures, the synergy index was 1.34.

"If these findings are confirmed, homocysteine levels may be a therapeutic target to reduce risk of cortical cataract in persons carrying genetic risk," the authors write.

One author was employed by Eisai.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Ground Beef Recalled After E. Coli Outbreak

Ground Beef Recalled After <i>E. Coli</i> Outbreak

Beef was produced and packaged at Cargill Meat Solutions in Fort Morgan, Colo.

Prevalence of Alzheimer's, Related Dementia Set to Double

Prevalence of Alzheimer's, Related Dementia Set to Double

Alzheimer's disease and related dementias burden is expected to increase to 3.3 percent in 2060

Long-Term Outcomes of Breast Implants Explored

Long-Term Outcomes of Breast Implants Explored

Higher rates of Sjogren syndrome, scleroderma, RA, stillbirth, melanoma for silicone implants

is free, fast, and customized just for you!




Already a member?

Sign In Now »